Rockwell Automation Life Sciences Automation and Information Solutions for Medical Device, Biotech and Pharmaceutical Digital Transformation

The biopharmaceutical manufacturing industry must be more agile and flexible than ever before. With a continuous need to manufacture blockbuster drugs, like GLP-1 analogs, manufacturers must now manufacture highly complex and personalized therapies as the market demands.Manufacturers are facing extreme challenges like exclusivity loss, price restrictions, market uncertainties, and more, which creates a shortened timeframe for profitability. 

With more pressure to lower cost of goods while increasing operational efficiency, implementing local production can help maximize access, minimize supply chain risks, all while combating yield, cost, and efficiency challenges.


Today, manufacturers need their facilities to be agile, execute near-seamless change-overs and quickly adapt to changes in demand. 


At Rockwell Automation, we can help you build your future today

Discover how the life sciences industry is harnessing smart manufacturing and emergent technology to drive long-term business impact, facilitate expansion and increased capacity, navigate supply chain and economic disruption, and overcome workforce challenges.

This report is based on responses from 143 decision makers from life sciences manufacturers, original equipment manufacturers (OEMs), engineering procurement companies (EPCs), and system integrators across 15 countries. It is part of Rockwell Automation’s 10th annual State of Smart Manufacturing report, which surveyed more than 1,500 decision makers across various industries.